Background. There is a heritable component to suicidal behaviour, encouraging the search for the associated risk alleles. Given the putative role of the 5-HT (5-hydroxytryptamine ; serotonin) system in suicidal behaviour, serotonergic genes are leading candidates. In particular, several studies have reported an association with variants in the tryptophan hydroxylase (TPH) gene.
INTRODUCTION
Deliberate self-harm (DSH) is the best predictor of future suicide (Sakinofsky, 2000) . Suicidal behaviour may result from a wide range of factors (Hawton & van Heeringen, 2000) . Psychiatric and personality disorders are present in most suicides and DSH patients, and comorbidity of disorders, especially mood and substance abuse disorders, is common (Suominen et al. 1996; Foster et al. 1997 ; Kessler et al. 1999 ; Haw et al. 2001) . In addition, impulsivity and aggression are traits of behavioural disinhibition that may underlie a cross-diagnostic propensity for suicidal behaviour (Brodsky et al. 1997; Roy, 2001 ; Van Praag, 2001 ).
Suicide and DSH show familial clustering (Roy, 1983 ; Roy et al. 2000 ; Hawton et al. 2002) . Twin and adoption studies show that this familiality is due mainly to genetic factors, which differ from the genetic predisposition to associated psychiatric disorders (Roy, 2001 ; Turecki, 2001) . The latter was confirmed by a recent case-control study, which found that suicide is independently associated with a family history of suicide, with an odds ratio of 2 . 58 (95 % CI, 1 . 84-3 . 61) (Qin et al. 2002 ). An Australian population-based twin study reported that additive genetic effects explained 45 % of the variance in suicidal thoughts and DSH (Statham et al. 1998) , while another twin study reported a 17% genetic contribution to DSH and 36 % to suicidal ideation (Fu et al. 2002) . These findings, in conjunction with the importance of suicide and DSH as public health issues, have focused attention on the search for the susceptibility genes for suicidal behaviour. Investigations to date have been almost entirely case-control association studies in which the frequencies of common polymorphisms in candidate genes have been compared between DSH (or suicide) subjects and a control group from the same population. The most widely studied genes have been those involved in 5-HT (serotonergic) neurotransmission, due to prior evidence of 5-HT dysfunction in suicidal individuals and suicide victims, and in associated factors such as impulsivity, aggression, and low mood (Mann, 1998) . For example, cerebrospinal fluid (CSF) levels of the major 5-HT metabolite, 5-HIAA (5-hydroxyindoleacetic acid), are reduced in suicide attempters (Å sberg et al. 1976) , and suicide victims and those with suicidal ideation exhibit differences in central expression of 5-HT receptors, especially the 5-HT2A receptor (HTR2A), and the 5-HT transporter (5-HTT) (see Mann, 1999) .
Several suggestive associations between serotonergic genes and either suicide or DSH have been reported, in particular with allelic variation in tryptophan hydroxylase (TPH) , HTR2A , 5-HTT (Du et al. 1999) and 5-HT1Db receptor (HTR1B) (New et al. 2001) . However, as reviewed by Turecki (2001) and Mann et al. (2001) , although the first two associations have been replicated at least once, other studies have failed to do so, while still others have reported associations with different serotonergic genes (see Discussion). To extend this body of work, we have examined these four polymorphisms, together with two other 5-HT-related candidate genes (5-HT2C receptor (HTR2C) and monoamine oxidase A (MAOA)), in a well-characterized sample of DSH subjects and a relatively large comparison group drawn from the same population.
METHOD Sample selection and recruitment
The subjects were patients aged 15 years and over who presented to the general hospital in Oxford following an episode of DSH. The definition of DSH was that given for 'parasuicide ' in the WHO/EURO Multicentre Study of Suicidal Behaviour (Platt et al. 1992) . From the 217 individuals approached, 150 took part in the original interview study, and from these, 129 (52 male, 77 female ; mean age 38 years (S.D.=14; range 20-72)) provided DNA for the present study. The demographic, psychiatric and personality characteristics of the 150 DSH patients have been documented in detail (Haw et al. 2001) ; the 129 patients studied here were demographically indistinguishable from the full sample. Subjects were assessed using a structured interview (Haw et al. 2001) , generating diagnoses according to ICD-10 research criteria (World Health Organization, 1993) . Subjects were also rated using the Beck Suicide Intent Scale (Beck et al. 1974) , the Brown-Goodwin Aggression Scale (Brown et al. 1979) , and the Plutchik Impulsivity Scale (Plutchik et al. 1989) .
The salient clinical characteristics of the sample were as follows. The majority (96 %) of the DSH acts were self-poisoning. Two-thirds had previously self-harmed at least once. Most (91 %) patients had an Axis I psychiatric disorder at index. The commonest diagnoses were depressive episode (72 %), alcohol harmful use or dependence (29 %), and neurotic/stressrelated disorders (16 %). Seventy-eight subjects (64 % from a total of 122) had a lifetime history of depressive disorder of at least moderate severity. A self-reported family history of suicide and/or DSH was present in 40 % of subjects (Hawton et al. 2002) .
The control sample comprised 329 individuals (138 male, 191 female), mean age 38 years (S.D.=13, range 19-71), recruited from blood donor clinics within Oxfordshire. It excluded individuals who reported any history of psychiatric disorder or current psychotropic medication in a self-report questionnaire. All DSH and control subjects were Caucasian and born in the UK, as were their parents and all four grandparents.
DNA extraction and genotyping
Participants provided two buccal swabs from which DNA was extracted using standard techniques (DNAce Clinipure Kit, Bioline, UK). Genotypes for the polymorphisms in the HTR2A, HTR2C, TPH, HTR1B and MAOA genes were determined using a previously described sequence-specific PCR assay (Marshall et al. 1999) . Briefly, the assay comprises two reactions -each consisting of the relevant allelespecific primer, the consensus primer, and two control primers (to determine amplification success). Allele-specific primers differ in the 3k-terminal nucleotide to allow the different genotypes to be discriminated (details on request). In reactions where the specific primer binds appropriately, two bands are observed -one for the allele specific PCR product and one for the control primer. Each reaction was carried out in a 13 ml volume consisting of 67 mM Tris base, pH 8 . 8; 2 mM magnesium chloride; 0 . 01% v/v Tween 20 ; 16 . 6 mM ammonium sulphate; 200 mM of each dNTP ; between 100-300 ng of DNA template ; and 0 . 2 U BioTaq DNA polymerase (Bioline). All primers were designed to operate within the same range of melting temperatures; the final primer concentrations were 192 pg/ml, with the exception of the HTR2C primers (96 pg/ml) and the control primers (38 pg/ml). Thermal cycling parameters consisted of an initial denaturation at 96 xC for 60 s followed by five cycles of 96 xC for 20 s, 67 xC for 45 s and 72 xC for 25 s. Two subsequent stages followed -first, 26 cycles of 96 xC for 25 s, 60 xC for 50 s and 72 xC for 30 s, then four cycles of 96 xC for 30 s, 55 xC for 60 s, and 72 xC for 90 s. Samples were cooled to 4 xC, centrifuged, and visualized on 1 . 5 % agarose gels containing 0 . 5 mg/ml ethidium bromide.
Genotyping of the 5-HTT LPR short/long promoter variant was determined separately, using primers directed to the adjacent upstream and downstream regions of the insertion/ deletion site. A 20 ml reaction volume consisted of 1 . 5 mM magnesium chloride; 200 mM of each dNTP ; 5 % dimethylsulphoxide ; approximately 200 ng of DNA template ; and 1 U BioTaq DNA polymerase together with the appropriate volume of 10X BioTaq reaction buffer. The final concentration of the forward (5k-GCG TTG CCG CTC TGA ATG C-3k) and reverse (5k-GGA CTG AGC TGG ACA ACC AC-3k) primers was 625 pg/ml. Cycling parameters were : 95 xC for 120 s, two cycles at 95 xC for 30 s, 63 xC for 30 s, and 72 xC for 60 s, prior to two cycles at 95 xC for 30 s, 62 xC for 30 s and 72 xC for 60 s, followed by 35 cycles at 95 xC for 30 s, 61 xC for 30 s and 72 xC for 60 s, with a final elongation step for 8 min at 72 xC. PCR fragments were resolved on a 3 % agarose gel and visualized with 0 . 5 mg/ml ethidium bromide.
Every polymorphism was genotyped twice for each individual, and alleles were scored independently by two people. For the few samples where there was an inconclusive result or discrepancy between duplicates, genotyping was repeated until an unequivocal genotype was obtained.
Statistical analysis
The primary analysis was the comparison of genotype and allele frequencies between cases and controls using x 2 tests. For the HTR2C and MAOA polymorphisms, men and women were analysed separately since males are hemizygous for X-linked genes. In addition, four planned secondary analyses were performed within the DSH sample, limited to those polymorphisms that showed a positive overall association with DSH in the present study, or where a prior association had been reported. The secondary analyses were : (1) the presence or absence of a lifetime history of major depression ; (2) the presence or absence of a family history of suicidal behaviour ; (3) the relationship with impulsivity, assessed using the Plutchik scale, for which scores ranged from 21-53, with a mean (S.D.) of 36 . 0 (6 . 4), available in 121 subjects ; (4) finally, we produced a composite score for risk of suicide (' suicide risk score '), which was the sum of the quartile scores obtained from the Brown-Goodwin Aggression Scale, the Beck Suicide Intent Scale, and the number of lifetime DSH episodes divided into quartiles. This gave a range of possible scores from 3 to 12, and was available for 120 of the DSH patients. In males, the suicide risk score ranged from 4 to 12, with a mean of 7 . 8, and in females ranged from 3 to 12, with a mean of 6 . 9.
RESULTS
Allele and genotype data for the six polymorphisms in the DSH and control groups are given for the autosomal genes in Table 1 , and the X-linked genes in Table 2 . All results were in Hardy-Weinberg equilibrium and were very similar to previously reported allele frequencies within Caucasian populations (Gelernter et al. 1997 ; Marshall et al. 1999) . The main positive finding is that the TPH A779 allele was more common in the DSH sample than in the controls (Table 1: OR=1 . 38, 95 % CI 1 . 02-1 . 88 ; P=0 . 03). There were no significant differences or trends between cases and controls for any of the other polymorphisms (all P>0 . 25).
Planned secondary analyses within the DSH group Table 3 summarizes the secondary analyses. No significant differences in allele or genotype frequencies were found related to a family history of DSH, lifetime history of depression, or with suicide risk scale or impulsivity score, for any of the four genes for which these planned comparisons were carried out. In addition, because of the finding of Evans et al. (2000) , we examined whether the HTR2C Ser23 variant was associated with impulsivity score, but found no such relationship (Cys, 36 . 7¡7 . 2, N=44; Ser, 38 . 8¡4 . 8; N=5).
DISCUSSION
Allelic variation in 5-HT-related genes and DSH We found a significant association between DSH and the A779 polymorphism of the tryptophan hydroxylase gene (Table 1) . (The A779 and C779 alleles are alternatively referred to as 'U ' and 'L ' respectively.) This replicates the original finding of Mann and colleagues (1997) in a group of subjects with major depression. The A779C polymorphism is in almost complete linkage disequilibrium with another TPH polymorphism, A218C. That is, virtually all individuals either have A alleles at both positions, or C alleles at both positions. Hence, it is notable that four studies have shown an association of suicidal behaviour with the A218 allele, since these are effectively also replications of the A779 finding (Persson, 1999 ; Abbar et al. 2001 ; Courtet et al. 2002) . These data together make a relatively convincing case that the A779/A218 variant of the TPH gene is associated with DSH. However, other results have been negative (Furlong et al. 1998 ; Zalsman et al. 2001) or equivocal (Geijer et al. 2000) , and no association has been found with completed suicide (Bennett et al. 2000 ; Du et al. 2000 b; Ono et al. 2000; Turecki et al. 2001) . Moreover, the opposite association (i.e. with the C779 allele) has also been reported (Nielsen et al. 1994 (Nielsen et al. , 1998 , albeit in a sample of alcoholic, violent offenders and arsonists, who represent a markedly different clinical population from that of typical DSH subjects.
The molecular mechanism by which the A779C and A218C polymorphisms might mediate their effects on DSH remains unclear. Both are intronic and therefore do not alter the amino-acid sequence. Two alternative possibilities remain : they may affect the processing of the TPH gene transcript (e.g. alter RNA splicing), or else they are merely markers of another, functional, variant which is in linkage disequilibrium with them both. The first possibility is unlikely since neither variant is associated with the production of aberrant TPH splice products . Recent evidence does lend some support to the second proposal. There are four polymorphisms within the TPH promoter sequence, which are in varying degrees of linkage disequilibrium with the A779C and A218C polymorphisms. Certain haplotypes (combinations of these polymorphisms) are more frequent in suicide attempters (Rotondo et al. 1999) and completers . Promoter polymorphisms have functional consequences by virtue of quantitative effects on expression of the gene. Although this has not been shown directly for TPH, preliminary evidence is consistent with the possibility (Rotondo et al. 1999) . Whatever the molecular mechanism, the polymorphism is functional, at least in men, with the A779 variant being associated with lower CSF 5-HIAA levels (Jonsson et al. 1997) and an attenuated prolactin response to fenfluramine (Manuck et al. 1999) . Previous studies of the 5-HTT LPR polymorphism and suicidal behaviour have produced conflicting results. The S (short) allele, which is associated with a lower basal transcriptional activity of the 5-HTT promoter, has been found to be more common in female suicide attempters (Baca-Garcı´a et al. 2002) and in alcoholics who attempt suicide, especially where the method is violent (Bondy et al. 2000) . Conversely, the long allele was reported to be more frequent in depressed suicide victims (Du et al. 1999) , and the LL genotype was more frequent in a subgroup of suicidal in-patients who scored highly for hopelessness and suicidal intent (Russ et al. 2000) . Several other reports indicate no association with either allele (Mann et al. 2000; Geijer et al. 2000) , and our finding (Table 1) adds to the tally of negative studies.
The HTR2A C102 allele has been associated with suicidal ideation and a history of suicidal behaviour (Arias et al. 2001) among patients with major depression. However, in line with three other studies of suicide and suicidal behaviour (Crawford et al. 1999 ; Tsai et al. 1999 b ; Turecki et al. 1999) we did not find any association of this polymorphism with DSH (Table 1) , or in the subgroup comparisons within the DSH sample (Table 3) . Moreover, Zhang et al. (1997) reported a weak association between DSH and the T102 allele. Overall therefore, as with the 5-HTT LPR polymorphism, there is no consistent evidence regarding a relationship between HTR2A gene variation and DSH. New et al. (2001) reported that the intronic G861 variant of the HTR1B gene was associated with a history of suicide attempt in personality disorder subjects. We did not find any association of this polymorphism with DSH (Table 1) or with any of the DSH subgroups (Table 3) . Our negative result is in line with the report by Huang et al. (1999) in suicide victims. We also found no association between DSH and the silent G941T polymorphism in the MAOA gene, in either men or women (Table 2 ), in agreement with Ho et al. (2000) . Frequencies for the HTR2C Cys23Ser polymorphism did not differ in this study between DSH and control men or women (Table 2) . There have been no prior investigations of this association with DSH, although the Ser23 variant has been associated with higher impulsivity scores in men, but not women, presenting after DSH (Evans et al. 2000) . We did not find a relationship between the Ser23 allele and impulsivity, rated with the Plutchik scale. A possible reason for the differing results is that Evans and colleagues (2000) used a different measure of impulsivity. They also had a larger sample, making our study relatively under powered to replicate the finding.
Methodological issues
Our findings are potentially affected by various limitations of case-control association studies (Malhotra & Goldman, 1999 ; Cardon & Bell, 2001 ). The first, hidden population stratification, is relatively unlikely given our careful matching of groups for ethnicity. In any event, recent empirical data suggest that it is less of a concern than was thought (Wacholder et al. 2000 ; Ardlie et al. 2002) . Secondly, like most studies in the field, our P values are uncorrected for multiple testing, and their interpretation must take into account the low prior probability that a given polymorphism, even within a convincing candidate gene, is truly associated with a trait. However, our positive finding with the TPH A779C allele was a replication, and so may be considered less vulnerable to this criticism ; moreover, we have not studied any polymorphisms other than those presented here, partially reducing the problem of multiple testing. We also note that there is no accepted statistical solution to the issue, and Bonferroni corrections may be inappropriate (Cardon & Bell, 2001) . Regarding the converse problemfalse negative results due to lack of power -our sample size was larger than most prior studies, for which the average has been approximately 90 DSH subjects and 100 controls (Roy, 2001; Turecki, 2001) . Furthermore, none of the polymorphisms showed a non-significant trend towards an association with DSH, which might be suggestive of a type II error (Tables 1 and 2 ). Nevertheless, because of the risks of false positive and false negative results, additional and larger studies are needed to confirm the present findings, as well as to ascertain the role of rarer allelic variants in serotonergic genes.
A strength of the present study is that the DSH sample was particularly well characterized (Haw et al. 2001; Hawton et al. 2002) , and representative of DSH patients attending hospital in the UK (with the exclusion of repetitive selfcutting). A weakness, as in most studies of behavioural phenotypes, is that we lacked full information about the relevant behaviour in the comparison group. Epidemiological studies indicate that between 1 . 1 and 4 . 6% of adults report a lifetime history of DSH (Moscicki, 1997; Kessler et al. 1999) and we assume that these data apply to blood donors. However, it seems highly unlikely that this could have confounded either the positive TPH A779 result, or the negative findings regarding the other polymorphisms.
A final question concerns the actual trait with which the TPH A779C polymorphism is associated. Genetic factors may be more closely related to intermediate phenotypes such as impulsivity, aggression, or severity of suicidal intent, rather than to DSH itself (e.g. Nielsen et al. 1998 ; Manuck et al. 1999 ; Evans et al. 2000) . For these reasons, we analysed the impulsivity score, and created the composite suicide risk score which included a measure of aggression. We found no evidence that either of these indices was related to the polymorphisms (Table 3 ), suggesting that these factors do not account for the association between DSH and the TPH A779 allele. However, it may instead be that the various scales do not adequately capture the behaviour of interest, or reflect the lack of power of these subgroup analyses. Also, there are many other variables about which we had no information and which might correlate with DSH; for example, the TPH A779 variant has been associated with smoking behaviours (Lerman et al. 2001 ; Sullivan et al. 2001) . These considerations indicate that future genetic studies will benefit from even more extensive characterization of subjects in both DSH and control groups.
Summary
The heritability of DSH, like that of other complex behavioural phenotypes, presumably reflects the influence of many genes and their interactions, both with each other, and with environmental factors. Association studies of the kind reported here provide initial clues as to the alleles and genes involved. However, they suffer from intrinsic limitations, as mentioned above. Therefore, while well-replicated positive results, such as the association between the TPH gene and DSH are noteworthy and merit further investigation, as well as meta-analyses when sufficient comparable data are available, significant progress in understanding the genetic contributions to suicidal behaviour will also require family-based association studies, genome-wide scans and haplotype analyses.
